NetForum uses cookies to ensure that we give you the best experience on our website. If you continue to use the site, we'll assume that you are happy to receive these cookies on the NetForum website. Read about our cookies.
NetForum Community
Learn. Share. Optimize.
Log in | Sign up now | Submit content | Contact

Attention valued NetForum members:

Due to evolving technology needs and global privacy regulations, we have made the hard decision to suspend the NetForum User Community platform on Friday, November 29, 2019.

After this date, the current NetForum can no longer be reached. Please click here for more information about this decision, what happens next and how to stay in touch with us about the future of the community.

Go to similar content

Liver imaging takes a step forward with Ingenia

Best Practice
Prof. Valette, Pierre-Jean, M.D. Lyon South Hospital, Hospices Civils de Lyon • France

The Lyon South Hospital (Lyon, France) is part of the Lyon University Hospital Center. It has nearly 1000 beds, mostly dedicated to cancer care, including oncology, radiotherapy, interventional radiology and surgery. The hospital uses Ingenia 3.0T and Ingenia 1.5T to perform about 800 MR exams a month, about 200 of which are for abdominal conditions.
 Prof. Pierre-Jean Valette, MD Lyon South Hospital (Lyon, France)
Prof. Pierre-Jean Valette, MD
Lyon South Hospital (Lyon, France)

Prof. Pierre-Jean Valette, MD, is Chief of Radiology and Nuclear Medicine Service at Lyon South Hospital. “In oncology patients, liver MRI is performed in several situations: to help us characterize lesions, in follow-up after chemotherapy, and to assist in treatment planning in a concept of multidisciplinary care when a complete tumor removal appears to be feasible,” he says. “So, we need our imaging to provide a comprehensive visualization of the liver and all lesions, their size, volume and location relative to other critical anatomical structures – such as bile ducts and portal branches – that influence tumor resectability. This helps determine the treatment options; it may be resection or tumor ablation or maybe radiotherapy.”

Challenges and goals in liver MRI

“MRI of liver tumors offers more than CT in certain aspects,” says Prof. Valette, “as it provides visualization and characterization of lesions with combined T1, T2 and DWI sequences, in addition to good tumor contrast uptake resolution and anatomical biliary tree imaging. Therefore, we always perform MRI before surgery or interventional radiology in case of bile duct tumor and liver primary cancers (HCC) or metastases.”

“Liver tumor MRI is almost always associated with CT and contrast-US for imaging,” he adds. “However, we think that MRI could become the sole examination as soon as it can provide image quality robustness similar to CT, better control of its inherent artifacts and increased spatial resolution for vascular imaging.”

View Case Studies:

Ingenia’s high image quality helps to overcome challenges

Lyon South Hospital installed Ingenia 3.0T in 2011, and an Ingenia 1.5T was recently added. Prof. Valette likes using the Ingenia’s dS Torso coil solution because it has a large coverage. “With this coil, whole abdomen acquisition is a single step for most patients. So, it is much faster to perform, for instance, bowel MRI for inflammatory diseases or tumors.” With the most recent Ingenia software release installed, Prof. Valette has worked to improve reproducibility, image quality and acquisition time of the hospital’s liver sequences. “We were able to realize improvements thanks to high dS SENSE in RL direction and improved MultiVane T2-weighted imaging. We are now convinced that we are on the way to definitely overcome the challenges. We optimized for image quality and control of artifacts. The arterial phase detection of very small liver or pancreatic hypervascular tumors is also improved.”

Only one MRI exam instead of multiple studies

“With all these improvements, I believe that resolution of vascular liver MR imaging is now approaching CT,” says Prof. Valette. “That’s important because we are moving from doing several studies - CT first, then MR or PET – to just one, and it’s saving a lot of time.”

“For instance, when assessing bile duct tumors, we need to see the location and boundaries of the tumor, but also the bile ducts adjacent to the tumor, the vessels, the hepatic artery, the portal vein, because all these are needed to determine whether the tumor is resectable or not. When we get, for example, bile duct images from MR or CT and the tumor on PET and maybe the vessels from CT, it’s difficult to combine all these views. And it means two or maybe three examinations have to be performed. The idea is to do everything with just one multiparametric technique, and that is MRI.”

A robust high quality MRI exam

Prof. Valette’s liver MRI includes some basic sequences and a set of optional sequences that may be used in special circumstances. “Our extended liver ExamCard includes a range of sequences for patients with limited capability to hold their breath, and also for obese patients,” he says. “If the patient is not able to maintain a breath hold we reduce the acquisition time by limiting the coverage to a selected region of interest and/or increase the voxel size, depending on the case.”

View or download ExamCard:

New way of patient positioning benefits image resolution

“Thanks to Ingenia’s wide 70 cm bore,” says Prof. Valette, “we have been able to improve our imaging strategy by implementing the high dS SENSE speedup in RL direction with arms-up patient positioning. This allows using a narrowed acquisition volume without the patient’s arms causing artifacts. This provides shorter breath hold times, higher resolution and sharper images because of reduced blurring in TSE and less distortion in DWI. This positioning is accepted by almost every patient, but requires an examination time not exceeding 20 to 25 minutes.”

“The use of high RL dS SENSE factors in combination with armsup provides a real advantage. So often with MR, when you change something, you lose something somewhere else. In this case, I see just advantages,” he concludes.

This content has been made possible by NetForum Community.
Share this on: Share your link in twitter Share your link in facebook Share your link on LinkedIn Print Rate this article: Log in to vote

Mar 6, 2014

Rate this:
Log in to vote

Best Practice
Ingenia 1.5T, Ingenia 3.0T
Release 4.1.3
Body, dS SENSE, dS Torso coil, dStream, Liver, Oncology

Clinical News
Best Practices
Case Studies
Publications and Abstracts
White Papers
Web seminars and Presentations
Application Tips and FAQ
Try an Application
Business News
Case Studies
White Papers
Web Seminars and Presentations
Utilization Services
Contributing Professionals
Contributing Institutions
Become a Contributor